Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis

Hepatology

Volumn 26, Issue 1, 1997, Pages 143-146

  Grove, Jane ^a   Daly, Ann K ^a   Bassendine, Margaret F ^a   Day, Christopher P ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0031009602     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260119     Document Type: Article

References (41)

1. Derr RF, Porta EA, Larkin EC, Ananda Rao G. Is ethanol per se hepatotoxic? J Hepatol 1990;10:381-386.
2. Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci 1975;252:85-105.
3. Day CP, Bassendine MF. Genetic predisposition to alcoholic liver disease. Gut 1992;33:1444-1447.
4. Hrubec Z, Omenn GS. Evidence of a genetic predisposition to alcoholic cirrhosis and psychosis; twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 1981;9:306-309.
5. Day CP, James OFW, Bassendine MF, Crabb DW, Li T-K. Alcohol dehydrogenase polymorphisms and predisposition to alcoholic cirrhosis [Letter]. HEPATOLOGY 1993;18:230-231.
6. Pirmohamed M, Kitteringham NR, Quest LJ, Allott RL, Green VJ, Gilmore IT, Park BK. Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetics 1995;5: 351-357.
7. Carr LG, Hartleroad JY, Liang YB, Mendenhall C, Moritz T, Thomasson H. Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men. Alcohol Clin Exp Res 1995;19:182-184.
8. McClain CJ, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis 1993;13:170-182.
9. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. HEPATOLOGY 1989;9:349-351.
10. Kamimura S, Tsukamoto H. Cytokine gene expression by kupffer cells in experimental alcoholic liver disease. HEPATOLOGY 1995;21:1304-1309.
11. Felver ME, Meze E, McGuire M, Mitchell MC, Herlong HF, Veech RL. Plasma tumor necrosis factor-α predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990;14:255-259.
12. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholics. HEPATOLOGY 1991;13:267-276.
13. Dèviere J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E. Excessive in vitro bacterial lipopolysaccharide-induced production of monokine in cirrhosis. HEPATOLOGY 1990;11:628-634.
14. Bird GLA, Sheron N, Goka AKJ, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917-920.
15. Ishii K, Furudera S, Kumashiro R, Koga Y, Hamada T, Sata M, Abe H, et al. Clinical and pathological features, and the mechanism of development in severe alcoholic hepatitis, especially in comparison with acute type fulminant hepatitis. Alcohol Alcohol 1993;28:97-103.
16. Schilling PJ, Murray JL, Markowitz AB. Novel tumor necrosis factor toxic effects. Pulmonary hemorrhage and severe hepatic dysfunction. Cancer 1992;69:256-260.
17. Wilson AG, de Vries N, Pociot F, di Giovinr FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor a promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993;177:557-560.
18. D'Alfonso S, Momigliano Richiardi P. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994;39:150-154.
19. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-511.
20. Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW. Effects of a tumor necrosis factor (TNF-α) promoter base transition on transcriptional activity [Abstract]. Br J Rheumatol 1994;33(Suppl 1):89.
21. Drouet C, Shakov AN, Jongeneel CV. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J Immunol 1991;147:1694-1700.
22. Ruwende C, McGuire W, Coleman E, Kwiatkowski D, Corrah T, Whittle H, Hill AVS. Association of a tumor necrosis factor promoter polymorphism with susceptibility to pulmonary tuberculosis [Abstract]. Clin Sxi 1996;90:3P.
23. Parés A, Cabellería J, Bruguera M, Torrés M, Rodés J. Histological course of alcoholic hepatitis. Influence of abstinence, sex, and extent of hepatic damage. J Hepatol 1986;2:33-42.
24. Yamauchi M, Maezawa Y, Toda G, Suzuki H, Sakurai S. Association of a restriction fragment length polymorphism in the alcohol dehydrogenase 2 gene with Japanese alcoholic liver cirrhosis. J Hepatol 1995;23: 519-523.
25. Enomoto N, Takase S, Takada N, Takada A. Alcoholic liver diseases in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes. HEPATOLOGY 1991;13:1071-1075.
26. Tsutsumi M, Takada A, Wang J-S. Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 1994;107:1430-1435.
27. Fong CJ, Siddiqui AH, Mark DF. Identification and characterisation of a novel repressor site in the human tumor necrosis factor α gene. Nucleic Acids Res 1994;22:1108-1114.
28. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987;4:8-14.
29. Day CP. Is necroinflammation a prerequisite for fibrogenesis? HepatoGastroenterology 1996;43:104-120.
30. Adamson GM, Billings RE. Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch Biochem Biophys 1992;294: 223-229.
31. Wright SC, Kumar P, Tam AW, Shen NP, Varma M, Larrick JW. Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 1992;48:344-355.
32. Adams DH. Leucocyte adhesion molecules and alcoholic liver disease. Alcohol Alcohol 1994;29:249-260.
33. Thornton AJ, Ham J, Kunkel SL. Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8 in human hepatoma and primary hepatocyte cultures. HEPATOLOGY 1991;14: 1112-1122.
34. Flesch IEA, Hess JH, Huang S Aguet M, Rothe J, Bluethmann H, Kaufmann SHE. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor a. J Exp Med 1995;181:1615-1621.
35. Saunders JB, Wodak AD, Haines A, Powelljackson PR, Portmann B, Davis M, Williams R. Accelerated development of alcoholic cirrhosis in patients with HLA-B8. Lancet 1982;1:1381-1384.
36. Bendtzen K, Morling N, Fomsgaard A, Svenson M, Kakobsen B, Odum N, Svejgaard A. Association between HLA-DR2 and production of tumor necrosis factor α and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 1988;28:599-606
37. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993;23:224-231.
38. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233-1237.
39. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 1995;211:833-839.
40. Deng GY, Maclaren NK, Huang H-S, Zhang L-P, She J-X. No primary association between the 308 polymorphism in the tumor necrosis factor α promoter region and insulin-dependent diabetes mellitus. Hum Immunol 1996;45:137-142.
41. Speilman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus. Am J Hum Genet 1993;52:506-516.